These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11932410)

  • 41. Coxsackievirus B3 induces apoptosis in the early phase of murine myocarditis: a comparative analysis of cardiovirulent and noncardiovirulent strains.
    Joo CH; Hong HN; Kim EO; Im JO; Yoon SY; Ye JS; Moon MS; Kim D; Lee H; Kim YK
    Intervirology; 2003; 46(3):135-40. PubMed ID: 12867750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
    Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
    J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Echovirus plays major roles in the natural recombination of Coxsackievirus B3.
    Shen H; Liu T; Luo Y; Shao S; Deng X; Wang H
    J Med Virol; 2018 Feb; 90(2):377-382. PubMed ID: 28851122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
    Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
    J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway.
    Si X; McManus BM; Zhang J; Yuan J; Cheung C; Esfandiarei M; Suarez A; Morgan A; Luo H
    J Virol; 2005 Jul; 79(13):8014-23. PubMed ID: 15956547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
    Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
    J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release.
    Si X; Luo H; Morgan A; Zhang J; Wong J; Yuan J; Esfandiarei M; Gao G; Cheung C; McManus BM
    J Virol; 2005 Nov; 79(22):13875-81. PubMed ID: 16254323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transfection of prion protein gene suppresses coxsackievirus B3 replication in prion protein gene-deficient cells.
    Nakamura Y; Sakudo A; Saeki K; Kaneko T; Matsumoto Y; Toniolo A; Itohara S; Onodera T
    J Gen Virol; 2003 Dec; 84(Pt 12):3495-3502. PubMed ID: 14645931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
    Henke A; Zell R; Ehrlich G; Stelzner A
    J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MCPIP1 inhibits coxsackievirus B3 replication by targeting viral RNA and negatively regulates virus-induced inflammation.
    Li M; Yan K; Wei L; Yang Y; Qian Q; Xu W
    Med Microbiol Immunol; 2018 Feb; 207(1):27-38. PubMed ID: 29043433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.
    Wessely R; Klingel K; Santana LF; Dalton N; Hongo M; Jonathan Lederer W; Kandolf R; Knowlton KU
    J Clin Invest; 1998 Oct; 102(7):1444-53. PubMed ID: 9769337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution.
    Tam PE; Messner RP
    J Virol; 1999 Dec; 73(12):10113-21. PubMed ID: 10559326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heat shock protein 70 promotes coxsackievirus B3 translation initiation and elongation via Akt-mTORC1 pathway depending on activation of p70S6K and Cdc2.
    Wang F; Qiu Y; Zhang HM; Hanson P; Ye X; Zhao G; Xie R; Tong L; Yang D
    Cell Microbiol; 2017 Jul; 19(7):. PubMed ID: 28095607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Construction of a subgenomic CV-B3 replicon expressing emerald green fluorescent protein to assess viral replication of a cardiotropic enterovirus strain in cultured human cells.
    Wehbe M; Huguenin A; Leveque N; Semler BL; Hamze M; Andreoletti L; Bouin A
    J Virol Methods; 2016 Apr; 230():1-8. PubMed ID: 26800776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
    Selinka HC; Wolde A; Pasch A; Klingel K; Schnorr JJ; Küpper JH; Lindberg AM; Kandolf R
    J Med Virol; 2002 Jun; 67(2):224-33. PubMed ID: 11992583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
    Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
    Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversion to wildtype of a mutated and nonfunctional coxsackievirus B3CRE(2C).
    Smithee S; Tracy S; Chapman NM
    Virus Res; 2016 Jul; 220():136-49. PubMed ID: 27130630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3.
    Jarasch N; Martin U; Kamphausen E; Zell R; Wutzler P; Henke A
    Viral Immunol; 2005; 18(2):355-64. PubMed ID: 16035947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.